Literature DB >> 16203397

The prospects of a harm reduction approach among indigenous people in Canada.

T C Landau1.   

Abstract

A harm reduction approach to alcohol and substance abuse is becoming increasingly popular as an alternative to prohibitionist and abstentionist policies. It is seen as particularly valuable for some high-risk populations, such as injection drug users and street youth. A strong argument can be made that Aboriginal communities in Ontario, Canada, and probably across the country, are appropriate environments for a harm reduction approach. Aboriginal people are at extremely elevated risk for accident, illness and death. At the same time, alcohol use is a predominant factor in many of these outcomes, and elevates many of the risks associated with Aboriginal life. Isolated, remote reserve communities in northern Ontario present additional risks of extremely poor living conditions and extreme weather conditions. Prohibition and abstinence are currently the main approaches to alcohol and substance abuse in many of these communities, while the role of alcohol in morbidity, mortality and other social problems remains high. There are positive indications that the feasibility of harm reduction strategies could be broached in some communities. It is concluded that the obstacles are significant but a community-by-community approach is a strong feature of harm reduction, and may increase its prospects for piloting strategies in individual communities.

Entities:  

Year:  1996        PMID: 16203397     DOI: 10.1080/09595239600186161

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  2 in total

1.  Substance abuse and developments in harm reduction.

Authors:  Y W Cheung
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

2.  Harm reduction acceptability and feasibility in a North American indigenous reserve community.

Authors:  Silvi C Goldstein; Nichea S Spillane; Tessa Nalven; Nicole H Weiss
Journal:  J Community Psychol       Date:  2022-04-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.